大众筛检市场：依产品类型、应用程式、性别、年龄层、交付方式、最终用户和地区划分

2025 年大规模筛检市场规模估计为 261 亿美元，预计到 2032 年将达到 377.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 5.42%。

全球大规模筛检市场已成为预防性医疗保健的重要组成部分，旨在及早发现和预防疾病。大规模筛检涉及对无症状人群进行系统性检测，以识别可能患有特定疾病的人群，从而及时干预并改善健康状况。随着世界面临日益加重的慢性病负担和不断上涨的医疗成本，有效的大规模筛检计画的重要性再怎么强调也不为过。该市场涵盖一系列筛检和测试，例如基因筛检、癌症筛检、心血管筛检和感染疾病筛检。在人工智慧和基因组学融合等技术进步的推动下，大规模筛检市场预计在未来几年将经历显着的成长和创新。

市场动态：

全球大规模筛检市场受多种因素驱动，包括慢性病盛行率上升、人们对疾病早期发现意识的增强以及政府推广预防性医疗保健的措施。癌症、糖尿病和心血管疾病等疾病负担日益加重，推动了对有效筛检方案的需求，这些方案能够识别高风险族群并及时介入。此外，液态切片、次世代定序医疗服务可近性有限，以及对假阳性结果和过度诊断的担忧。此外，围绕基因筛检和资料隐私的监管挑战和伦理考量也可能成为市场成长的障碍。儘管面临这些挑战，大规模筛检市场仍为相关人员提供了重大机会。远端医疗和远端监控解决方案的日益普及可能会扩大筛检方案的覆盖范围，尤其是在医疗服务不足的地区。此外，大规模筛检与药物基因组学和风险分层等个人化医疗方法相结合，可以实现有针对性的干预并优化患者的治疗效果。随着全球医疗保健系统更加重视预防医学和成本效益，大规模筛检市场预计将在未来几年见证显着的成长和创新。

本研究的主要特点

• 本报告对全球大规模筛检市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。
• 它强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球大规模筛检市场的主要企业概况。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球大规模筛检市场报告涵盖该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员可以透过用于分析全球大规模筛检市场的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 限制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020 年至 2032 年全球大规模筛检市场（依产品类型）

• 硬体设备
• 检验服务
• 结果分析与解释

第五章。 2020 年至 2032 年按应用分類的全球大规模筛检市场

• 肿瘤学
• 心臟病学
• 免疫学
• 神经病学
• 遗传学和基因组学
• 内分泌与代谢
• 感染疾病
• 生殖及孕产妇健康
• 小儿科/新生儿科
• 精神病学和心理健康
• 血液学
• 胃肠病学
• 肾臟病学

6. 全球大规模筛检市场（依性别划分），2020 年至 2032 年

• 男性
• 女士

7. 2020 年至 2032 年按年龄分類的全球大规模筛检市场

• 儿科族群
• 成年人口
• 老年人口

8. 2020 年至 2032 年按交付类型分類的全球大规模筛检市场

• 现场/设施筛检
• 远距/远端医疗检查
• 流动检查组
• 自我检测/在家检测

9. 全球大规模筛检市场（以最终用户划分），2020 年至 2032 年

• 医院
• 诊断实验室
• 学术研究所
• 政府和公共卫生机构
• 专科诊所
• 其他的

第 10 章。 2020 年至 2032 年按地区分類的全球大规模筛检市场

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争格局

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• QIAGEN
• Hologic
• PerkinElmer
• Illumina
• Cepheid
• Genomic Health
• Agilent Technologies
• Ortho Clinical Diagnostics
• Becton, Dickinson and Company
• Beckman Coulter

第 12 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十三章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Population Screening Market is estimated to be valued at USD 26.10 Bn in 2025 and is expected to reach USD 37.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.42% from 2025 to 2032.

The global population screening market has emerged as a crucial aspect of preventive healthcare, aiming to detect and prevent diseases at an early stage. Population screening involves the systematic testing of asymptomatic individuals to identify those at risk of developing specific conditions, enabling timely intervention and improved health outcomes. As the world faces an increasing burden of chronic diseases and rising healthcare costs, the importance of effective population screening programs cannot be overstated. This market encompasses various screening tests, including genetic screening, cancer screening, cardiovascular screening, and infectious disease screening, among others. With advancements in technology, such as the integration of artificial intelligence and genomics, the population screening market is poised for significant growth and innovation in the coming years.

Market Dynamics:

The global population screening market is driven by several factors, including the rising prevalence of chronic diseases, increasing awareness about early disease detection, and government initiatives to promote preventive healthcare. The growing burden of diseases such as cancer, diabetes, and cardiovascular disorders has heightened the need for effective screening programs to identify at-risk individuals and enable timely intervention. Moreover, advancements in screening technologies, such as liquid biopsy, next-generation sequencing, and AI-powered imaging analysis, are expected to enhance the accuracy and efficiency of screening tests, further driving market growth. However, the market also faces certain restraints, such as high costs associated with screening tests, limited access to healthcare services in certain regions, and concerns regarding false-positive results and overdiagnosis. Additionally, regulatory challenges and ethical considerations surrounding genetic screening and data privacy may pose obstacles to market growth. Despite these challenges, the population screening market presents significant opportunities for stakeholders. The increasing adoption of telehealth and remote monitoring solutions has the potential to expand the reach of screening programs, particularly in underserved areas. Furthermore, the integration of population screening with personalized medicine approaches, such as pharmacogenomics and risk stratification, can enable targeted interventions and optimize patient outcomes. As healthcare systems worldwide focus on preventive care and cost-effectiveness, the population screening market is expected to witness substantial growth and innovation in the coming years.

Key Features of the Study:

• This report provides in-depth analysis of the global population screening market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global population screening market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Hologic, PerkinElmer, Illumina, Cepheid, Genomic Health, Agilent Technologies, Ortho Clinical Diagnostics, Becton, Dickinson and Company, and Beckman Coulter.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global population screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global population screening market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Hardware Equipment
  • Diagnostic Devices
  • Sample Collection Devices
  • Imaging Equipment
  • Testing or Laboratory Services
  • Laboratory Testing Kits
  • Point-of-Care Testing
  • Blood and Urine Testing Services
  • Analytics or Interpretation
  • Software Solutions for Data Analysis
  • Interpretation Services
  • Reporting Tools
  • Others
• Application Area Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology
  • Cardiology
  • Immunology
  • Neurology
  • Genetics and Genomics
  • Endocrinology and Metabolism
  • Infectious Diseases
  • Reproductive and Maternal Health
  • Pediatrics and Neonatology
  • Psychiatry and Mental Health
  • Hematology
  • Gastroenterology
  • Nephrology
• Gender Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Pediatric Population
  • Adult Population
  • Elderly Population
• Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
  • Onsite/Facility-Based Screening
  • Remote/Telehealth Screening
  • Mobile Screening Units
  • Self-Testing/Home-Based
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Government and Public Health Agencies
  • Specialty Clinics
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Roche Diagnostics
  • Abbott Laboratories
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • QIAGEN
  • Hologic
  • PerkinElmer
  • Illumina
  • Cepheid
  • Genomic Health
  • Agilent Technologies
  • Ortho Clinical Diagnostics
  • Becton, Dickinson and Company
  • Beckman Coulter

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Population Screening Market, By Product Type
  • Global Population Screening Market, By Application Area
  • Global Population Screening Market, By Gender
  • Global Population Screening Market, By Age Group
  • Global Population Screening Market, By Delivery Mode
  • Global Population Screening Market, By End User
  • Global Population Screening Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Population Screening Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hardware Equipment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Diagnostic Devices
    • Sample Collection Devices
    • Imaging Equipment
• Testing or Laboratory Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Laboratory Testing Kits
    • Point-of-Care Testing
    • Blood and Urine Testing Services
• Analytics or Interpretation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Software Solutions for Data Analysis
    • Interpretation Services
    • Reporting Tools
    • Others

5. Global Population Screening Market, By Application Area, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetics and Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrinology and Metabolism
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Reproductive and Maternal Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatrics and Neonatology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Psychiatry and Mental Health
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gastroenterology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nephrology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Population Screening Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Population Screening Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pediatric Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Adult Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Elderly Population
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Population Screening Market, By Delivery Mode, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Onsite/Facility-Based Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Remote/Telehealth Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mobile Screening Units
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Self-Testing/Home-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Population Screening Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Government and Public Health Agencies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Population Screening Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application Area, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Delivery Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• QIAGEN
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PerkinElmer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Illumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cepheid
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genomic Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ortho Clinical Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us